TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life.
Luca RicheldiPietro SchinoElena BargagliAlberto RicciAlberto RoccaFrancesca MarchesaniAlfio PennisiGianna CamiciottoliMaria D'AmatoFrancesco MacagnoUlrica Scaffidi ArgentinaEleonora IngrassiaAlessio PirainoPublished in: International journal of chronic obstructive pulmonary disease (2024)
TRITRIAL showed that the BDP/FF/G fixed combination is effective and safe in patients with moderate-severe COPD and poorly controlled disease, improving patients' HRQoL, sleep quality, adherence and inhaler usability and reducing COPD symptoms and the risk of exacerbation in a real-life setting.
Keyphrases
- sleep quality
- chronic obstructive pulmonary disease
- end stage renal disease
- lung function
- ejection fraction
- depressive symptoms
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- healthcare
- type diabetes
- physical activity
- high intensity
- metabolic syndrome
- adipose tissue
- glycemic control
- insulin resistance